Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Consultation record

Consultations on methodology documents

3 consultations on documents of this type.

Consultations

3 documents
  • CEI-CP-032OpenMethodology31 Jul 2026 – 28 Aug 2026

    Consultation on the fourth version of the Institute's methodology document, which describes how a question is registered, how evidence is searched and screened, how certainty is rated, how a document is reviewed and ratified, and how it is…

    21 submissions3 not accepted
  • CEI-CP-036ClosedMethodology02 Nov 2024 – 14 Dec 2024

    Consultation on the search-strategy template used across the synthesis series: the databases searched, the structure of the strategy, the handling of registry records without posted results, and the requirement that a strategy be published…

    19 submissions2 not accepted
  • CEI-CP-001ClosedMethodology02 May 2024 – 27 Jun 2024

    Consultation on the second version of the framework the Institute uses to rate certainty in a body of evidence. The revision retains the four-level GRADE scale and alters the way the two lowest ratings are explained, after the assessment…

    15 submissions2 not accepted
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.